Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy

Objective: One of the major goals of cancer treatment is the monitoring of chemotherapeutic protocols. Quantitative and comparative cytokine expression profiling could be reliable to be used for biomarkers in deadly and fast-growing cancers such as acute myeloid leukemia (AML). The present study aim...

Full description

Bibliographic Details
Main Authors: Sepehrizadeh, Zargham, Mohammadi, Mohammad, Emami, Amirhossein, Yazdi, Mojtaba Tabatabaei, Bozchlou, Saeed Hashemi, Khorramizadeh, Mohammad Reza, Shapourabadi, Mina Bahrololoumi, Jaberi, Elham, Rajaei, Naghmeh, Setayesh, Neda
Format: Online
Language:English
Published: Galenos Publishing 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102042/
id pubmed-4102042
recordtype oai_dc
spelling pubmed-41020422014-07-17 Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy Sepehrizadeh, Zargham Mohammadi, Mohammad Emami, Amirhossein Yazdi, Mojtaba Tabatabaei Bozchlou, Saeed Hashemi Khorramizadeh, Mohammad Reza Shapourabadi, Mina Bahrololoumi Jaberi, Elham Rajaei, Naghmeh Setayesh, Neda Research Article Objective: One of the major goals of cancer treatment is the monitoring of chemotherapeutic protocols. Quantitative and comparative cytokine expression profiling could be reliable to be used for biomarkers in deadly and fast-growing cancers such as acute myeloid leukemia (AML). The present study aims to assess and further validate cytokines with probable effects on proliferation and maturation of blood cells in AML. Galenos Publishing 2014-06 2014-06-10 /pmc/articles/PMC4102042/ /pubmed/25035672 http://dx.doi.org/10.4274/tjh.2012.0164 Text en © Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Sepehrizadeh, Zargham
Mohammadi, Mohammad
Emami, Amirhossein
Yazdi, Mojtaba Tabatabaei
Bozchlou, Saeed Hashemi
Khorramizadeh, Mohammad Reza
Shapourabadi, Mina Bahrololoumi
Jaberi, Elham
Rajaei, Naghmeh
Setayesh, Neda
spellingShingle Sepehrizadeh, Zargham
Mohammadi, Mohammad
Emami, Amirhossein
Yazdi, Mojtaba Tabatabaei
Bozchlou, Saeed Hashemi
Khorramizadeh, Mohammad Reza
Shapourabadi, Mina Bahrololoumi
Jaberi, Elham
Rajaei, Naghmeh
Setayesh, Neda
Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy
author_facet Sepehrizadeh, Zargham
Mohammadi, Mohammad
Emami, Amirhossein
Yazdi, Mojtaba Tabatabaei
Bozchlou, Saeed Hashemi
Khorramizadeh, Mohammad Reza
Shapourabadi, Mina Bahrololoumi
Jaberi, Elham
Rajaei, Naghmeh
Setayesh, Neda
author_sort Sepehrizadeh, Zargham
title Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy
title_short Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy
title_full Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy
title_fullStr Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy
title_full_unstemmed Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy
title_sort assessment of cytokine expression profile in acute myeloid leukemia patients before and after chemotherapy
description Objective: One of the major goals of cancer treatment is the monitoring of chemotherapeutic protocols. Quantitative and comparative cytokine expression profiling could be reliable to be used for biomarkers in deadly and fast-growing cancers such as acute myeloid leukemia (AML). The present study aims to assess and further validate cytokines with probable effects on proliferation and maturation of blood cells in AML.
publisher Galenos Publishing
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102042/
_version_ 1613115228186214400